Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,896 | -61,210 | -48,731 | -21,548 | -107,979 |
| Depreciation Amortization | 5,130 | 7,211 | 4,881 | 2,457 | 5,566 |
| Accounts receivable | -12,246 | -13,122 | 1,665 | -1,067 | 781 |
| Other Working Capital | -76,468 | -9,526 | 3,165 | -1,162 | -6,498 |
| Other Operating Activity | 45,004 | 23,181 | 5,254 | 3,741 | 10,017 |
| Operating Cash Flow | $-61,476 | $-53,466 | $-33,766 | $-17,579 | $-98,113 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 140 | 142 | -216 | -112 | 1,113 |
| Other Investing Activity | -890 | -659 | 0 | 0 | -9,264 |
| Investing Cash Flow | $-750 | $-517 | $-216 | $-112 | $-8,151 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,979 | -2,189 | -1,421 | -687 | -2,492 |
| Common Stock Issued | 370 | 288 | 230 | 127 | 103,628 |
| Other Financing Activity | 320 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-2,289 | $-1,901 | $-1,191 | $-560 | $101,136 |
| Exchange Rate Effect | -294 | 1,329 | 975 | 1,600 | -1,897 |
| Beginning Cash Position | 156,384 | 156,184 | 156,184 | 156,184 | 163,209 |
| End Cash Position | 91,575 | 101,629 | 121,986 | 139,533 | 156,184 |
| Net Cash Flow | $-64,809 | $-54,555 | $-34,198 | $-16,651 | $-7,025 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,476 | -53,466 | -33,766 | -17,579 | -98,113 |
| Capital Expenditure | -814 | -644 | -377 | -247 | -1,119 |
| Free Cash Flow | -62,290 | -54,110 | -34,143 | -17,826 | -99,232 |